Study finds delay in follow-up among African-American women receiving abnormal breast finding

October 26, 2009

A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that African-American women may face obstacles to receiving appropriate breast cancer-related care.

In the United States, and particularly South Carolina, African-American women suffer disproportionately higher mortality rates from breast cancer compared to white women. Studies have indicated that African-American women experience significantly longer time intervals from an abnormal mammogram to diagnostic testing or are less likely to comply with recommended diagnostic follow-up exams within six months of an abnormal mammogram.

To investigate further, Swann Arp Adams, MS, PhD, of the University of South Carolina in Columbia, and her colleagues studied medical data from participants of the Best Chance Network, a state-wide service program that provides free mammography screenings to economically disadvantaged and medically underserved women. The program is part of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Dr. Adams and her team analyzed tumor characteristics and patients' adherence to recommended tests following abnormal mammograms.

While African-American women were just as likely as white women to complete diagnostic procedures after abnormal mammography findings, there was a significantly longer time between the first clinical exam and to complete a diagnostic follow-up (median time = 44 days for African Americans and 40 days for European Americans). When time was measured in the number of days between the mammogram and the date of final status, a significant effect of race was no longer evident. Because the clinical breast examination typically precedes the diagnostic mammogram, these findings suggest that the racial differences may occur early in the process. While the reasons for the delay are unknown, they may result from poor communication between patient and doctor, lack of patient trust in her doctor, lack of transportation, proximity of clinics to the patient, and other factors.

The researchers say evidence indicates delayed follow-up of breast abnormalities can result in detecting the breast cancer at a later stage, pointing to one study that found a delayed diagnosis of breast cancer of as little as three months is associated with lower survival than those with prompt follow-up.

The researchers add that the finding of no disparities existing in the overall completion of the follow-up is an encouraging evaluation of the NBCCEDP, as it suggests that the program is making progress toward eliminating racial disparities in breast cancer and offer areas for strengthening.

"Programs specially aimed at providing breast cancer screening to economically disadvantaged women like the National Breast and Cervical Cancer Early Detection Program are successful in eliminating some of the racial disparities seen in breast cancer," said Dr. Adams. "There are still improvements that could be made in the program to help identify and eliminate barriers to timely completion of testing procedures," she added.
-end-
Article: "Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women." Swann Arp Adams, Emily Rose Smith, James Hardin, Irene Prabhu Das, Jeanette Fulton, and James R. Hebert. Cancer; Published Online: October 26, 2009 (DOI: 10.1002/cncr.24633); Print Issue Date: December 15, 2009.

American Cancer Society

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.